PIN64 Assessing the Cost-Effectiveness (CE) of Vaccinating the Elderly and at-Risk Adults With the 23-Valent Pneumococcal Polysaccharide Vaccine (PPV23) Compared to the 13-Valent Pneumococcal Conjugate Vaccine (PCV13) or no Vaccination (NoV ...
Nov 1, 2012, 00:00
10.1016/j.jval.2012.08.1131
https://www.valueinhealthjournal.com/article/S1098-3015(12)02844-6/fulltext
Title :
PIN64 Assessing the Cost-Effectiveness (CE) of Vaccinating the Elderly and at-Risk Adults With the 23-Valent Pneumococcal Polysaccharide Vaccine (PPV23) Compared to the 13-Valent Pneumococcal Conjugate Vaccine (PCV13) or no Vaccination (NoV ...
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(12)02844-6&doi=10.1016/j.jval.2012.08.1131
First page :
A396
Section Title :
Infection
Open access? :
No
Section Order :
633